Surna Inc. — FY2020 Form 10-K Summary
Filing identity: The supplied filing is for Surna Inc. (ticker SRNA), not CEA Industries Inc. It covers the fiscal year ended December 31, 2020; it is an annual report, not a standalone fourth-quarter report. Financial comparisons below are FY2020 versus FY2019 unless otherwise stated.
Business context and reporting period
Surna designs, engineers and sells climate-control equipment, engineering services, and automation and control systems for controlled-environment agriculture (CEA). Most historical customers cultivate cannabis, although management aims to broaden into non-cannabis indoor agriculture. Surna does not grow or sell cannabis. Its shares traded on the OTCQB.
Financial performance and position
| Metric | FY2020 / Dec. 31, 2020 | FY2019 / Dec. 31, 2019 |
|---|---|---|
| Revenue | $8.514 million | $15.224 million |
| Gross profit / gross margin | $1.553 million / 18.2% | $4.549 million / 29.9% |
| Operating loss | $2.363 million | $1.311 million |
| Net loss | $1.759 million | $1.339 million |
| Adjusted net loss (non-GAAP) | $1.239 million | Adjusted net income of $92,000 |
| Cash from operating activities | $818,000 | $672,000 |
| Cash and cash equivalents | $2.285 million | $922,000 |
| Working capital deficit | $2.220 million | $1.437 million |
| Backlog at year-end | $8.448 million | $9.558 million |
Cost of revenue was $6.961 million, down from $10.676 million. Operating expenses fell 33% to $3.916 million, largely reflecting reduced stock-based compensation and pandemic-related spending cuts. Cash provided by operations was supported by working-capital movements, including higher deferred revenue and lower inventory; it did not represent operating profitability.
At year-end, Surna reported no debt, but had $3.724 million of deferred revenue, $1.785 million of accounts payable and accrued liabilities, and current operating-lease liabilities of $266,000. Total liabilities were $6.147 million, exceeding total assets of $4.813 million. The company reported an accumulated deficit of $27.444 million and shareholders’ deficit of $1.334 million. The filing says a $554,000 bank loan received in April 2020, plus accrued interest, was forgiven in December 2020. In February 2021, Surna received a separate $514,200 bank loan at 1% interest, due in 2026 and potentially forgivable subject to its terms.
Material changes versus FY2019
- Revenue declined 44%, while net bookings fell about 55%, from $16.3 million to approximately $7.4 million. The company cited first-half project delays and cancellations, including a major cancellation; bookings rebounded in the second half.
- Gross margin fell 11.7 percentage points to 18.2%, reflecting the fixed-cost burden at lower sales, lower equipment margins and higher variable costs as a share of revenue.
- Net loss widened by $420,000 despite lower operating expenses. Net other income of approximately $604,000—principally loan forgiveness and a legal judgment—partly offset the operating loss.
- Year-end cash increased by $1.363 million, while the working-capital deficit worsened by $783,000. Backlog declined 12% year over year.
- Three customers represented 28%, 11% and 10% of FY2020 revenue; one customer represented 44% in FY2019. One multi-facility operator contributed 28% of 2020 revenue.
Outlook, commentary, risks and unusual items
- Going concern and financing: The auditor included a going-concern explanatory paragraph, citing recurring losses, a working-capital deficiency and accumulated deficit. Management said cash and operating cash flow would be insufficient for the next 12 months without improved revenue, cash generation, additional financing or further cost reductions. Additional financing may be unavailable or dilutive.
- Backlog conversion: Management reported $8.448 million of backlog, but emphasized that it may not become revenue, or may be delayed. About $2.643 million (31%) was engineering-only paid; customers still need to progress to equipment orders. The company expects $8.058 million of backlog to be recognized in 2021 and $390,000 in 2022, subject to uncertainty.
- COVID-19: The pandemic disrupted demand and projects. Surna reduced headcount, hours, compensation, travel and marketing, then restored staffing and compensation as activity recovered. Management warned that continued disruption could reduce sales, margins and operating cash flow.
- Strategy: Management is focusing on multi-facility operators, a broader range of lower- and mid-priced products, SentryIQ controls, retrofit and recurring services, and partnerships. It stated that it did not find suitable strategic partners in 2020. No quantified revenue or earnings guidance was provided.
- Regulatory and industry exposure: Cannabis remains illegal under U.S. federal law despite state legalization, creating risks to customers, financing, contracts and Surna’s operations. Other risks include customer project financing and permitting, competition, customer and supplier concentration, supply-chain disruption, and cannabis price declines.
- Controls and reporting: Management concluded that disclosure controls and internal control over financial reporting were ineffective at year-end due to insufficient accounting expertise and supervision, inadequate segregation of duties, and weak spreadsheet controls. The material weakness was unchanged from 2019.
- Unusual items and contingencies: A one-time warranty issue involving three projects contributed to approximately $402,651 of accrued expenses for repairs; management said it was not expected to recur. A former employee continues to pursue disputed consulting fees; any potential loss was not reasonably estimable. The company had collected a separate arbitration judgment in its favor.
Key facts investors should verify
- Confirm the issuer identity: this filing names Surna Inc., not CEA Industries Inc.
- Review the audited financial statements and cash-flow detail to assess the quality and sustainability of positive operating cash flow.
- Track liquidity, working-capital needs, the February 2021 loan’s repayment or forgiveness status, and any new financing or dilution.
- Test backlog conversion against actual revenue, cancellations and customer advances, especially the engineering-only paid contracts.
- Monitor customer concentration, gross-margin recovery, and the commercial adoption and profitability of new products and controls.
- Check whether management remediates the disclosed material weakness and whether subsequent filings change the going-concern assessment.
- Review subsequent-event disclosures, including the loan, employee option awards and related-party consulting agreement.